Published in J Urol on February 18, 2019
Editorial Comment. J Urol (2019) 0.75
Stereotactic body radiation therapy could improve disease control in oligometastatic patients with renal cell carcinoma: do we need more evidence? Ann Transl Med (2019) 0.75
Stereotactic body radiation therapy for oligometastatic renal cell carcinoma: improving outcomes in an otherwise radioresistant malignancy. Ann Transl Med (2019) 0.75
Role of stereotactic body radiation therapy for the management of renal cell carcinoma: tailoring treatment in the era of the "embarrassment of riches". Ann Transl Med (2019) 0.75